The esteemed Thai National Health Security Office (NHSO) is musing over a potential enhancement to its bountiful offerings under the highly lauded 30-baht healthcare all-encompassing package, colloquially recognized as the “gold card” schema. The future inclusion in the revered scheme might robustly span over cancer-related medical aid and complimentary screenings for those yet to obtain their gold card.
In a notable announcement, the authoritative secretary-general of the NHSO, Jadet Thammathat-Aree, revealed his organization’s audacious projections to radically spread its wings in the realm of cancer therapy and diagnostics. The NHSO’s central objective of making medical intervention cost-effective for common residents remains the driving force behind this initiative. The health office’s meticulous explorations span across exploring potential pharmaceutical aids worthy of being added to the esteemed national list of essential medicines.
Delving into the specifics, Jadet Thammathat-Aree elucidated the ongoing dialogue between the NHSO and prominent pharmaceutical entities. The objective of this discourse is to lay the groundwork for the dispensation of targeted therapies, a medical necessity integral to countless cancer patients’ treatment regimen. Mr. Thammathat-Aree especially underscored the urgency of this for survivors waging their brave battle against breast cancer.
He expressed, “Our revamped benefits nested within the gold card program will primarily zero in on various cancers. However, the scheme necessitates rigorous policy dialogues. We are passionately striving to champion routine health screenings before the advent of illness, as early disease interception drastically amplifies the likelihood of recuperation.”
In a positive development, the NHSO’s influential secretary-general divulged that possible coverage for an additional, popular drug is currently undergoing painstaking review. The medication, namely cytisine — a primary aid to give up smoking — has been subjected to robust advocacy to grace the national list of essential medicines.
The proactive NHSO isn’t shying away from underscoring the pivotal role of preventive health screenings, especially for newborns and rare diseases’ cancer tests. While it is steadily marching towards full-scale prevention, Mr. Thammathat-Aree candidly accepted that their current preventive measures haven’t reached the expected objectives—the annual cervical cancer screenings modestly touch 1.6 million women.
However, Thammathat-Aree believes that encouraging individuals to embrace at-home health tests could potentially catalyze screening numbers to a staggering five million women. Collaborating with the Social Security Office, the NHSO seeks to involve non-member groups like factory workers, who often skip early cancer screening tests, in its preventive healthcare initiatives.
Jadet Thammathat-Aree concluded by highlighting the yearly surplus funds the office receives, which could be channeled towards supporting health promotion and disease prevention endeavors for susceptible groups, not enrolled under the generous gold card scheme.
For more gripping stories, stay connected with us on our new Facebook page: FOLLOW US NOW!
Be First to Comment